IMAGING OF HYPERPOLARIZED SUBSTRATES IN ANIMAL MODELS OF CANCER

癌症动物模型中超极化基底的成像

基本信息

  • 批准号:
    8171670
  • 负责人:
  • 金额:
    $ 0.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Measurement of in vivo metabolism has outstanding potential for the diagnosis and monitoring of cancer, because metabolism accurately reports the tumor's biological state. An ongoing challenge in cancer imaging is to increase the number of biological features that can be viewed in vivo and correlated with tumor growth, genetics, or response to therapy. So far, "metabolic imaging" in cancer has been limited to snapshots of nutrient uptake (e.g. FDG-PET) and steady-state levels of a few abundant metabolites like lactate and choline (magnetic resonance spectroscopy). In principle, imaging based on nuclear magnetic resonance (NMR) could significantly widen the view of tumor metabolism because it would allow the user to observe the transfer of 13C from labeled probes to products by enzymatic reactions in live tissue. NMR can be integrated with MRI-based imaging to map metabolic activities to precise anatomic locations, including tumors. The major obstacle to extending NMR spectroscopy into clinical practice is the low abundance and sensitivity of the 13C nuclear spin, resulting in a low signal-to-noise ratio. Recently, however, the advent of dynamic nuclear polarization ("hyperpolarization") has drastically increased the feasibility of real-time, NMR-based imaging of metabolism in vivo. In this technique, polarization of the 13C nuclear spin state is greatly enhanced by transfer from the high spin polarization of an unpaired electron from a free radical. Although transient, this gain in polarization translates into a 10,000-fold (or greater) improvement in signal-to-noise ratio. We hypothesize that hyperpolarization of naturally-occurring metabolites like pyruvate will enable us to monitor the metabolism of live tumors in animal models of cancer. The major goal of the project is to develop methods to obtain high-resolution images of metabolic activity in tumor-bearing mice. The proposal draws on our experience using stable isotope methods to study tumor metabolism and using hyperpolarization to monitor metabolic activity in isolated cells and perfused organs. The proposed activities are the next logical step towards our goal of developing hyperpolarization as a clinical tool for diagnosing human cancer and monitoring its response to therapy. This project will benefit from concurrent activities within the Research Resource. The proposed experiments will cover the three major categories of mouse models of tumor growth: subcutaneous xenografts, tumors implanted at an orthotopic site, and a transgenic model of tumorigenesis. There are three aims: 1) Image pyruvate metabolism in subcutaneous tumors derived from cancer cell lines. 2) image pyruvate metabolism in orthotopic gliomas, and 3) image pyruvate metabolism in a mouse model of spontaneous breast cancer.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RALPH J DEBERARDINIS其他文献

RALPH J DEBERARDINIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RALPH J DEBERARDINIS', 18)}}的其他基金

Metabolic Regulators of Tumor Growth and Progression
肿瘤生长和进展的代谢调节因子
  • 批准号:
    10472535
  • 财政年份:
    2017
  • 资助金额:
    $ 0.52万
  • 项目类别:
Metabolic Regulators of Tumor Growth and Progression
肿瘤生长和进展的代谢调节因子
  • 批准号:
    9762588
  • 财政年份:
    2017
  • 资助金额:
    $ 0.52万
  • 项目类别:
Metabolic Regulators of Tumor Growth and Progression
肿瘤生长和进展的代谢调节因子
  • 批准号:
    10238924
  • 财政年份:
    2017
  • 资助金额:
    $ 0.52万
  • 项目类别:
Metabolic Regulators of Tumor Growth and Progression
肿瘤生长和进展的代谢调节因子
  • 批准号:
    9389673
  • 财政年份:
    2017
  • 资助金额:
    $ 0.52万
  • 项目类别:
Human metabolic variation as a window into cancer initiation and progression
人类代谢变异是了解癌症发生和进展的窗口
  • 批准号:
    10736053
  • 财政年份:
    2017
  • 资助金额:
    $ 0.52万
  • 项目类别:
Project 2: Defining Targetable Metabolic Dependencies in Human Renal Cell Carcinoma
项目 2:定义人类肾细胞癌的靶向代谢依赖性
  • 批准号:
    10708840
  • 财政年份:
    2016
  • 资助金额:
    $ 0.52万
  • 项目类别:
Project 3: Clinically Actionable Biomarkers from Renal Cell Carcinoma Metabolism and Imaging
项目 3:肾细胞癌代谢和影像学中临床可行的生物标志物
  • 批准号:
    9071072
  • 财政年份:
    2016
  • 资助金额:
    $ 0.52万
  • 项目类别:
Metabolic Regulators of Tumor Cell Growth
肿瘤细胞生长的代谢调节剂
  • 批准号:
    8843997
  • 财政年份:
    2011
  • 资助金额:
    $ 0.52万
  • 项目类别:
Metabolic Regulators of Tumor Cell Growth
肿瘤细胞生长的代谢调节剂
  • 批准号:
    8842458
  • 财政年份:
    2011
  • 资助金额:
    $ 0.52万
  • 项目类别:
Metabolic Regulators of Tumor Cell Growth
肿瘤细胞生长的代谢调节剂
  • 批准号:
    8657905
  • 财政年份:
    2011
  • 资助金额:
    $ 0.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了